跳至主導覽 跳至搜尋 跳過主要內容

Defining risk groups of patients with cancer of unknown primary site and cervical nodal metastases by F-18 fluorodeoxyglucose positron emission tomography and computed tomography imaging

  • Yung Yueh Su
  • , Shih Shin Chen
  • , Jason Chia-Hsun Hsieh
  • , Chun Ta Liao
  • , Chien Yu Lin
  • , Chung Jan Kang
  • , Tzu Chen Yen*
  • *此作品的通信作者
  • Chang Gung Memorial Hospital
  • LinkouChang Gung Memorial Hospital

研究成果: 期刊稿件 › 文章 › 同儕審查

3 引文 斯高帕斯(Scopus)

摘要

We sought to investigate the clinical utility of F-18 fluorodeoxyglucose (FDG) positron emission tomography and computed tomography (PET/CT) in Taiwanese patients with cancer of unknown primary site (CUP) and cervical nodal metastases. We also aimed to study the impact of F-18 FDG PET/CT on clinical treatment priority in this patient group. Between September 2006 and May 2014, patients with CUP and cervical nodal metastases who underwent F-18 FDG PET/CT imaging study were retrospectively identified. The clinicopathological risk factors and PET parameters were analyzed in relation to 2-year overall survival (OS) rates using univariate and multivariate analyses. Two-year OS curves were plotted with the Kaplan–Meier method. Of the eligible patients (n = 54), 12 (22.2%) had distant metastases (DM) at presentation. A total of 13 (24.1%) and 15 (27.8%) primary tumors were identified by FDG PET/CT imaging and an additional triple biopsy, respectively. The results of multivariate analysis identified smoking [p = 0.033, 95% confidence interval (CI) = 1.197−40.342], a maximum standardized uptake value (SUVmax) of cervical nodes ≥ 14.2 (p = 0.035, 95% CI = 1.134−28.029), and DM at presentation (p = 0.031, 95% CI = 1.257−114.854) as independent predictors of 2-year OS. Specifically, patients who carried ≥ 2 risk factors showed poorer outcomes (70.3% vs. 11.8%, p < 0.001). Fifteen study patients (27.8%) had their treatment modified by FDG PET/CT findings. We conclude that FDG PET/CT is clinically useful in CUP patients not only for tumor staging, but also for modifying treatment regimens.

原文英語
頁(從 - 到)407-413
頁數7
期刊Kaohsiung Journal of Medical Sciences
卷32
發行號8
DOIs
出版品狀態已出版 - 01 08 2016
對外發佈是

文獻附註

Publisher Copyright:
© 2016

UN SDG

此研究成果有助於以下永續發展目標

  1. SDG3 健康與福祉
    SDG3 健康與福祉

指紋

深入研究「Defining risk groups of patients with cancer of unknown primary site and cervical nodal metastases by F-18 fluorodeoxyglucose positron emission tomography and computed tomography imaging」主題。共同形成了獨特的指紋。

引用此